Patients within a well-organized, high-volume, urban ST-segment elevation myocardial infarction network were found to have comparable management and 1-year outcomes when admitted in a primary percutaneous coronary intervention center during on-hours or off-hours.
Patients admitted to the hospital for myocardial infarction with a known diagnosis of obstructive sleep apnea were found to have improved in-hospital mortality.
The efficacy of melatonin, which has shown a prophylactic antidepressant effect in breast cancer, was explored given the prevalence of depressive symptoms after ACS.
Estimated pulse wave velocity predicted outcomes independent of the Framingham Risk Score, indicating an incremental role of markers of aortic stiffness on cardiovascular risk.
Anticoagulants, antiplatelets, and thrombolytics for the treatment and/or prophylaxis of venous and arterial thrombosis.
Compared with current standard of care, implantation of a device for intracardiac ST-segment monitoring and alerting in people who are at high risk for recurrent ACS resulted in a significant decrease in median pre-hospital delay.
Use of sex-specific thresholds identified 5 times more additional women than men with myocardial injury.
Study data indicate a significantly increased risk for MACE among patients with depressive disorder who have early or late stage ACS.
For patients with ACS, having a gradual onset of symptoms is associated with longer prehospital delay.
Study demonstrates for the first time in a randomized trial a return of vasomotion after device resorption by the use of bioresorbable scaffold technology in comparison to permanent drug-eluting stent.
